Concepedia

Yuqin Song

YS

Statistics

Publications

4

Citations

257

H-Index

4

Active since

2022

Affiliations

Peking University Cancer Hospital(Current)

Peking University

Henan Cancer Hospital

Zhengzhou University

The University of Texas MD Anderson Cancer Center

Yuqin Song is an author at Peking University Cancer Hospital specializing in oncology pharmacotherapy, pharmacology, and hematologic malignancy therapy.

Publications per year

2022–2025

4

Publications

4

Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study

Yuqin Song, Keshu Zhou, Dehui Zou et al. · Blood · 2022 · 169 citations · Full text

, , +16

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

Michael Wang, David Šálek, David Belada et al. · Journal of Clinical Oncology · 2025 · 48 citations · Full text

, , +11

Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma

Franck Morschhauser, Gilles Salles, Laurie H. Sehn et al. · Journal of Clinical Oncology · 2025 · 26 citations · Full text

, , +13

Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies

Wei Xu, Shenmiao Yang, Constantine S. Tam et al. · Advances in Therapy · 2022 · 14 citations

, , +9

1–4 of 4